ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on X

Kidney Week

Translational Session

Treatment Development in IgA Nephropathy

November 04, 2023 | 04:30 PM - 06:00 PM

Location: Room 201, Pennsylvania Convention Center

Session Description

IgA nephropathy is a rare kidney disease that, until recently, had no treatment options. Over the last decade, a robust pipeline of treatment options for IgA nephropathy are in clinical trials. This session highlights patient perspective, trial design, emerging therapies, and the collaboration between the US Food and Drug Administration (FDA), investigators, and industry required to make new therapies possible.

ASN thanks the Kidney Health Initiative for assistance with this session.
Session support is provided by an educational grant from Travere Therapeutics, Inc.

Learning Objective(s)

  • Examine the trial design and endpoints in IgA nephropathy
  • Discuss the perspective of a parent whose child was diagnosed with IgA nephropathy
  • Explain how collaborations among researchers, industry, and the FDA opened opportunities for new translational science
  • Summarize emerging therapies in IgA nephropathy

Learning Pathway(s)

  • Glomerular Diseases
  • CKD Non-Dialysis